Lin−CCR2+ hematopoietic stem and progenitor cells overcome resistance to PD-1 blockade

oleh: Catherine T. Flores, Tyler J. Wildes, Jeffrey A. Drake, Ginger L. Moore, Bayli DiVita Dean, Rebecca S. Abraham, Duane A. Mitchell

Format: Article
Diterbitkan: Nature Portfolio 2018-10-01

Deskripsi

Brain tumors are difficult to treat using existing immunotherapeutic strategies. Here, the authors show that in brain tumors resistant to PD-1 blockade, HSCs expressing CCR2+ can reverse treatment resistance and sensitizes mice to immunotherapy.